<?xml version="1.0" encoding="UTF-8"?>
<p>Rapid response against HFMD in children is imperative to prevent the progress of the infection into the CNS, as the latter has serious outcomes. As prophylactic and therapeutic agents have not been well established internationally, surveillance, and functional studies including development of new antivirals and balanced multivalent vaccines is critically important to reduce disease burden in pediatric populations. </p>
